144 related articles for article (PubMed ID: 14586208)
1. Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.
Barbieri F; Alama A; Tasso B; Boido V; Bruzzo C; Sparatore F
Invest New Drugs; 2003 Nov; 21(4):413-20. PubMed ID: 14586208
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and multidrug resistance reversal activity of phenothiazine derivative is strongly enhanced by theobromine, a phytochemical from cocoa.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Poła A; Dzięgiel P; Puła B; Świątek P; Wesołowska O
Eur J Pharmacol; 2019 Apr; 849():124-134. PubMed ID: 30721703
[TBL] [Abstract][Full Text] [Related]
3. "Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).
Cimoli G; Valenti M; Noviello E; Parodi S; Mazzoni A; Rovini E; De Sessa F; Russo P
J Cancer Res Clin Oncol; 1995; 121(3):155-63. PubMed ID: 7713987
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.
Alaoui Jamali MA; Yin MB; Mazzoni A; Bankusli I; Rustum YM
Cancer Chemother Pharmacol; 1989; 25(2):77-83. PubMed ID: 2598402
[TBL] [Abstract][Full Text] [Related]
5. Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
Perry WL; Shepard RL; Sampath J; Yaden B; Chin WW; Iversen PW; Jin S; Lesoon A; O'Brien KA; Peek VL; Rolfe M; Shyjan A; Tighe M; Williamson M; Krishnan V; Moore RE; Dantzig AH
Cancer Res; 2005 Aug; 65(15):6593-600. PubMed ID: 16061639
[TBL] [Abstract][Full Text] [Related]
6. The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Świątek P; Majkowski M; Wesołowska O
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813251
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.
Vikhanskaya F; Clerico L; Valenti M; Stanzione MS; Broggini M; Parodi S; Russo P
Int J Cancer; 1997 Jul; 72(1):155-9. PubMed ID: 9212237
[TBL] [Abstract][Full Text] [Related]
8. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
9. Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line.
Mahdizadeh S; Karimi G; Behravan J; Arabzadeh S; Lage H; Kalalinia F
Daru; 2016 Jun; 24(1):17. PubMed ID: 27342070
[TBL] [Abstract][Full Text] [Related]
10. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
Minko T; Kopecková P; Pozharov V; Kopecek J
J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
[TBL] [Abstract][Full Text] [Related]
11. Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.
Vanhoefer U; Voigt W; Hilger RA; Yin MB; Harstrick A; Seeber S; Rustum YM
Oncol Res; 1997; 9(9):485-94. PubMed ID: 9495454
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.
Mazzoni A; Trave F
Oncol Res; 1993; 5(2):75-82. PubMed ID: 8364256
[TBL] [Abstract][Full Text] [Related]
14. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
15. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
16. Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.
Tsakovska I; Pajeva I
Curr Drug Targets; 2006 Sep; 7(9):1123-34. PubMed ID: 17017890
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.
Minko T; Kopecková P; Kopecek J
J Control Release; 1999 May; 59(2):133-48. PubMed ID: 10332049
[TBL] [Abstract][Full Text] [Related]
19. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
20. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer].
Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
